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AUROTHIOGLUCOSE OBESITY IN THE MOUSE
In 1816 William Wadd" remarked that "corpulency" occurred very fre-
quently after the use of mercury in the treatment of syphilis, and he stated
that preparations containing this metal ". . . might almost be recommended
as specific agents for bringing about the accumulation of fat." The next
observation linking a heavy metal with obesity was made by Brecher and
Waxler,a who reported in 1949 that striking obesity often occurred in mice
injected with a large dose of aurothioglucose (ATG), a compound that had
been used in 1927 by Lande' for the treatment of arthritis.
Brecher and Waxler' demonstrated that a single injection of ATG can
produce massive and persistent obesity in mice, but that it is necessary to
use a dose of the compound which approximates its L.D.50 (lethal dose) to
secure this effect. A variable number of the survivors of such a dose
(usually about a third) exhibit obesity of varying degree. It was clearly
shown that the obesity is related to a marked increase in spontaneous food
intake, and that there is a close correlation between increased food intake
and the extent of the obesity.
Our present knowledge of this chemically-induced form of obesity can be
summarized as follows: (i) Different strains of mice appear to be variably
susceptible to the toxic effect of ATG.' (ii) The syndrome has been seen
only in the mouse, although Waxler and Brecher"' have attempted to repro-
duce it in guinea pigs, rats, rabbits, and puppies. (iii) Obese mice have no
apparent difficulty in mobilizing their depot fat, and, after periods of starva-
tion, they overeat and become obese again.' (iv) Histological study of
tissues from obese mice has revealed no lesions in the central nervous sys-
tem or elsewhere which might contribute to an understanding of increased
food intake.8"' (v) A thioglucose compound without gold did not produce
obesity in mice, while gold thiomalate injections resulted in only slightly
excessive weight gain."2
The present report is concerned with two aspects of the problem. First,
studies concerning the mechanism of production of obesity by aurothio-
* This study was made during tenure of a State University of New York Pre-
doctoral Fellowship.
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glucose will be described; and second, certain experiments which are related
to possible adaptive responses to chronic overnutrition will be presented.
This bipolar approach to the problem may be justifiable on two grounds:
a better understanding of the mechanism of induction of obesity by auro-
thioglucose will yield interesting information about the operation of the
hunger-satiety apparatus of normal animals. Secondly, a study of the meta-
bolic impact of overnutrition on animals may provide a basis for a clearer
comprehension of the patho-physiology of a number of "degenerative"
diseases.9
MATERIALS AND METHODS
Approximately 1,500 female albino mice (Bio Lab Breeding Institute & Albino
Farms) were used in this study. They were maintained in groups at a temperature of
about 260 C., and were permitted free access to water and to a diet of Purina Dog
Chow unless otherwise noted.
Aurothioglucose ("Solganal," supplied generously by Dr. Norman Heminway of the
Schering Corporation) was used either as a sesame oil suspension containing 100 mgs.
per ml. or (in later experiments) as a freshly prepared aqueous solution of a water-
soluble powder. Injections were made either intraperitoneally or intramuscularly as
noted.
Mouse tail blood samples (0.05 ml.) were analyzed for glucose content by the Nelson
modification' of the Somogyi method. Liver fat content of 500 mg. samples was esti-
mated by a modification of a method suggested by Payne.' The solvent was Bloor's
reagent, and every precaution was taken to prevent evaporation of the solvent during
filtration. Nitrogen was estimated on 50 mg. liver samples by a modification of the
method of Koch and McMeekin.' Serum cholesterol determinations were performed
according to the method of Sperry and Schoenheimer.'
The Haldane open circuit method'2'7 was used for estimation of oxygen consumption
of intact mice in the fed state. Oxygen consumption of liver slices was measured in a
standard Barcroft-Warburg apparatus in phosphate buffer at pH 7.4, with oxygen as
the gas phase.
Endocrine organs were weighed on a Roller Smith Torsion Balance, and tissues to
be examined histologically were fixed in 10% formalin.
In all studies of obesity incidence reported herein a weight of 45 grams was arbi-
trarily selected as the minimum weight indicating the presence of obesity. The mean
weights of different groups of uninjected controls varied between 27 and 33, and it was
only extremely rarely that a control animal attained a weight of 40 grams. Most of the
obese mice used in the experiments described in Part II weighed 55 grams or more.
Mice which attained a weight of 80 grams or more were seen with some regularity.
The maximum weight seen in this laboratory was 96 grams.
A purified pituitary growth hormone preparation was kindly supplied by Mr. Irby
Bunding of the Armour Laboratories (Lot No. R491024).
Probabilities were estimated according to student's test of "t."'0
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EXPERIMENTAL DESIGN AND RESULTS
PART 1. THE INDUCTION OF OBESITY BY AN INJECTION OF AUROTHIOGLUCOSE
1. The effect of fasting on toxicity and obesity incidence due to aurothio-
glucose.
In accordance with a suggestion by Brecher,' one mg. of aurothioglucose
in oil per gram of body weight was injected intramuscularly into fed mice
and into mice fasted for 24 hours. Food was withheld for an additional 22
hours from the fasted group, while the control group was permitted free
access to food. The results are shown in Table 1. There is an indication that
starvation increased both the survival rate and the incidence of obesity. In
addition, a larger number of mice in the fasted groups attained extremely
TABLE 1. THE EFFECT OF FASTING ON TOXICITY AND OBESITY INCIDENCE
FOLLOWING A SINGLE INJECTION OF AUROTHIOGLUCOSE IN SESAME OIL
Dose of ATG No. mice Per cent Per cent obese of
Nutritional state mgs./gm. injected survivors survivors
Fasted 1.0 200 23 53
Fed 1.0 110 11 33
heavy weights. For example, the maximum weight observed in the fasted
group was 91 grams, with many mice reaching 80 grams or more. The
maximum weight observed in the fed group was 75 grams. The mean
weight of sesame oil-injected controls in this series was 28 grams.
2. Aurothioglucose toxicity in carbohydrate diet and fat diet-adapted mice.
The increased rate of survival in the fasted group in Experiment 1
suggested the possibility that some metabolic concomitant of starvation
exerts a protective effect against ATG. Since starvation and fat-feeding
have many metabolic similarities, it was decided to test the effect of fat-
feeding on ATG toxicity.
Accordingly, synthetic diets were prepared in which isocaloric quantities
of lard and a glucose-sucrose mixture were added respectively to a basal
amount of protein, (21 per cent of the total calories) salts, and vitamins.
Groups of mice, which weighed from 11-16 grams, were fed these diets for
a period of six weeks. At the end of that time they were injected intra-
peritoneally with 0.8 mgs. of ATG per gram of body weight. A smaller
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group of chow-fed controls was fasted for 24 hours and injected at the same
time. The results of this experiment are given in Table 2.
It will be seen that the mean body weight of the fat-fed mice at the time
of injection was distinctly higher than that of the chow diet group, and thus,
the mice in the former group received a slightly larger absolute dose of
ATG than did the controls. The survival rate of the fasted chow-fed mice
and the fed carbohydrate-fed ones was not strikingly different in this experi-
ment, while the survival rate of the fat-fed mice was so much lower than
that of the other two groups that the result could hardly have been due to a
TABLE 2. AUROTHIOGLUCOSE TOXICITY IN CARBOHYDRATE DIET AND FAT DIET-
ADAPTED MICE
Mean body
ATG* No. ofmice wt. gm.s.
Diet group mgs./gm. injected Injection timne Per cent survival
Fat 0.8 137 28 17
Carbohydrate 0.8 110 25 40
Chowt 0.8 50 23 50
* Aqueous, i.p.
t Fasted 24 hours before and 22 hours after injection.
12 per cent increase in absolute dose. This result clearly differentiates fat-
feeding from starvation as far as the susceptibility to ATG intoxication is
concerned.
3. The effect of treatment with Dimercatopropanol (BAL) on toxicity and
obesity incidence due to ATG
Many observations of the sort reported in experiments 1 and 2 led to an
inquiry into whether or not the lethality of ATG could be shown to be
separable from its obesity-producing potency. Apparently, this was accom-
plished to a certain extent in the starvation experiment, in which it was
found that more mice survived and more of the survivors became obese.
The following question was asked: if mice could be protected from dying a
heavy metal death, would obesity-incidence be unaffected, and would it,
therefore, be possible to increase the yield of obese mice per 100 injected?
In an attempt to answer this question mice were injected intramuscularly
with 1 mg./gm. of ATG and BAL according to three different schedules.
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Survival and obesity incidence were observed for a period of four months.
The results are shown in Figure 1. It is obvious that, as protection against
the lethal properties of the compound became more pronounced, the
incidence of obesity among the survivors markedly diminished.
4. The effectiveness of ATG at two wuidely different blood glucose levels
The experiments with BAL suggested the possibility that the gold
portion of the ATG molecule is essential to its capacity to produce obesity.
The thioglucose moiety is closely related to glucose, and may contribute
substantially to the effectiveness of the compound as an obesity-producing
agent.
Per cent. survivors Per cent. obese
Total dose (of total injected) (of survivors)
ATO SAL
mg./Gm m./Gm. 100 75 50 25 t0 20 30
I 0 (00)f
1 0.12 15 doses) (40)
I 0.18(3doses) (70)
I + 0.16 (1O0)
(combined
before injection)
FIG. 1. The effect of treatment with dimercaptopropanol (BAL) on toxicity and
obesity incidence after aurothioglucose injection.
Recently, Mayer and his associates"8"' have amplified earlier ideas into
an elaborate hypothesis which they call the "glucostatic theory of food
intake regulation." Some features of this hypothesis were used in designing
the following experiment: there are glucoreceptors in the body which signal
satiety to integrating centers as the concentration of glucose (or some meta-
bolic derivative of glucose) in the body fluids and, subsequently, in the re-
ceptor cells themselves rises. The function of these cells can be permanently
impaired by a single injection of aurothioglucose. The similarity in struc-
ture between glucose and ATG suggests the possibility of a competitive
relationship between the two substances for a protein surface in the hypo-
thetical receptor cells. Therefore, it was suggested that a very large excess
of glucose in the body might serve to protect the hypothetical receptors
from combination with ATG.
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Accordingly, two similar groups of mice were fasted for 24 hours. The
mice in Group A were injected intraperitoneally with 60 mgs. of glucose in
0.3 cc. of 0.9 per cent saline. Fifteen minutes later tail blood samples were
obtained from 25 representative mice and all were immediately injected
with 0.7 mg./gm. of ATG (aqueous) intraperitoneally. Tail blood samples
were obtained from 25 mice in group B and all of them were then injected
with ATG as in the case of group A. Food was returned to both groups and
survival and obesity incidence were observed over a four-month period. The
results of the experiment are seen in Figure 2. Instead of protecting the
No. mice Btood Glucose2 p.c.survivors p.c. obese ot of of
Injecfed Injection time injected survivors
75 50 25 10 20
92 197mgs.p.c.
90 65 mgs.p.c.
1 O.7mgs./Gm.body wt.
2 Meon of 25 mice in each group
FIG. 2. The effect of antecedent glucose injection on toxicity of aurothioglucose1 and
on obesity incidence.
mice from ATG intoxication it is clear that, as a consequence of the glucose
injection, the mice in the hyperglycemia group showed an enhanced suscep-
tibility to the compound. Furthermore, there was a tendency toward an
increased incidence of obesity among the survivors.
PART II. SOME EFFECTS OF LONG-ESTABLISHED ATG OBESITY ON THE MOUSE
1. Carbohydrate metabolism
In view of the well-recognized relationship between obesity and impair-
ment of carbohydrate tolerance in the human' and in other forms of
experimental obesitye glucose tolerance tests were performed on a group
of representative obese mice and on appropriate controls in the fed state.
Glucose was injected intraperitoneally in a total volume of 0.3 to 0.4 ml. of
solution. The control mice were given a dose of 1 mg. of glucose per gram
of body weight, while the fat mice were all given 42 mgs. of glucose, which
represented about a 40 per cent increase over that given as the mean control
dose. Tail blood samples were obtained at 15, 45, and 90 minutes after
glucose injection. The tests were repeated on each mouse after an interval
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of four to eight weeks, and the means for each animal were used for Table
3, which shows the results of the experiment.
In spite of the fact that the obese mice weighed approximately three times
as much as did the controls, and although they had been markedly obese for
at least two months, their glucose tolerance curves did not differ much from
those of the controls. The only noteworthy result of this experiment is the
fact that the curves of the obese mice varied over a much wider range than
did the control curves. It is possible that the extremely flat curves (1,587
area units) and the elevated ones (3,485 area units) represent enhanced
and impaired glucose tolerance respectively. It should be noted that these
mice were studied a maximum of five months after ATG injection.
TABLE 3. GLUCOSE TOLERANCE OF ATG OBESE MICE AND CONTROLS
No. of Glucose tolerance area*
No. of mice observations Mean Range
Controls 5 10 2,446 2,070-2,975
Obese 5 10 2,583 1,587-3,485
* Arbitrary area units (inches 'xlO0).
A parenthetical remark by Mayer' suggested the possibility that ATG
obese mice might be hypersensitive to the hyperglycemic effect of certain
growth hormone preparations. Accordingly, ten obese mice (50-79 gms.)
and eight controls (30-38 gms.) were injected with four mgs. of Growth
Hormone (Armour, Wilhelmi type). Ten other obese mice and eight suit-
able controls were similarly injected with crystalline bovine plasma albumin.
Tail blood samples taken before and 24 hours after injection showed no
discernible effect of either the Growth Hormone or the albumin on the
blood glucose.
2. Fat metabolism
Previous studies of hypothalamic obese rats' showed striking increases in
the fat content of the liver and in serum cholesterol and serum fatty acids
over the levels found in control animals. It was of interest, therefore, to
study these parameters in ATG obesity.
A highly significant increase in fat content over control values was found
in the livers of ten obese mice. Similarly, there was a statistically significant
increase in serum cholesterol in the obese mice (see Fig. 3).
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3. Studies on the so-called "hypermetabolism of obesity"
There has been some uncertainty about the significance of measurements
of oxygen consumption in obese animals. For example, it has been sug-
gested that obese humans show hypermetabolism as compared with people
of "ideal weight (see Evans').
Liver
Fat
Per cent.
of
Wet weight
Serum
Cholesterol
in
mgs. P.C.
10
9
8
7
6
5
4
3
2
125
100
75
50
25
P
<0.01
i -
l
PA- * & - IK - 1%A - . controls
FIG. 3. Liver fat and serum cholesterol
concentrations in aurothioglucose mice
and controls.
Uoese
Body Weight
in
Grams
OXYGEN
CONSUMPTION
cc./hr.
100
75
50
25
4
0.7 cc./gm. /hr. 5
cc.m.ideal'wt./ 3
hr.
Controls (8) Obese (8)
P <0
in <0.009
>0.5
n <001 1
FIG. 4. The oxygen consumption of
aurothioglucose mice and controls.
The nature of the supposed "hypermetabolism" of obesity has never been
clearly elucidated. It was planned, therefore, to study the problem in ATG
obese mice in an effort to obtain an answer to the following question: Does
the high absolute oxygen consumption of the chronically overnourished
animal signify an increase in rate of metabolism of an unchanged mass of
contributory tissue, or is marked obesity due to chronic overnutrition invari-
ably accompanied by an increase in the "active metabolic mass" of the
animal?
Eight obese mice (mean weight 73.4 gms.) and eight controls (29.9
gms.) were selected for this part of the study. The total oxygen consump-
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tion was estimated at least twice for each mouse, and the means for each
animal were used for the calculations shown in Figure 4. It will be seen
that there is a very marked increase in absolute oxygen consumption in the
obese group. When the oxygen consumption is recalculated on the basis of
a power function of the body weight which approximates surface area,'
there is no difference between the groups. Recalculation on the basis of
"ideal" weight reveals a significant difference between the groups.
75r
50
mM3QA/g.N/ hr.
25
75
Total livte N
moq. s0
25
9- -& .-
Control
FIG. 5. The oxygen
surviving liver slices
cose mice and contrc
total hepatic nitrogen
two groups of mice.
The nature of this difference was
clearly demonstrated by the next ex-
4 periment. Animals similar to those de-
scribed above were sacrificed and the
oxygen consumption of their surviving
p * liver slices was measured in a Barcroft-
>O5 Warburg apparatus. Since it had been
determined that the obese mice showed
fatty infiltration of the liver, the results
were expressed not as Qo2 but as
mm302 consumed per mg. nitrogen per
hour. On this basis, liver slices ob-
p | tained from fat mice and those obtained
o0.0l from controls were quite indistinguish-
Is(10) Obese(10) able from one another (see Fig. 5).
consumption of The absolute increase in oxygen con- of aurothioglu-
As shown with sumption of the fat mice, then, can be
values for the attributed to the fact that, probably as
a consequence of chronic overnutri-
tion, they have acquired an increased "active metabolic mass," a true
splanchnomegaly. This is evident not only in the liver nitrogen figures in
Figure 5 but also in the section to follow.
4. Autopsy data on ATG obese mice and controls
At the time of sacrifice (five to seven months after injection) most of
the obese mice appeared to be in good health. They did not show skin
lesions on the legs or loss of hair such as are sometimes seen in old, hypo-
thalmic obese rats.' Nose-to-anus and tail length measurements revealed no
difference between the obese mice and their controls.
When the abdominal cavity was opened, massive deposits of fat were
found in the subcutaneous tissue and in the mesentery (see Fig. 6). There
was a clearly evident splanchnomegaly; all of the abdominal viscera in the
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FIG. 6. A typical aurothioglucose mouse and a control at autopsy.
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extremely obese mice appeared to be very much larger than in the controls.
In many instances the livers of the obese mice were yellow.
Weights of certain representative organs are summarized in Table 4. It
will be seen that the proportionate increase in liver, heart, and kidney
weight is of the same order of magnitude. It is of some interest that the
increase in absolute oxygen consumption for this group of obese mice was
about 79 per cent over the control value.
TABLE 4. ORGAN WEIGHTS AT AUTOPSY IN A REPRESENTATIVE GROUP OF TEN
OBESE MICE AND TEN CONTROLS. FIGURES IN PARENTHESES
DESIGNATE RANGE
Weight in grams
Controls Obese Per cent of control
Body 29.1 72.1 248
(24.5-32.5) (61.5-82.5)
Liver 1.75 + S.E. 0.09 3.0 + S.E. 0.22 172
(1.4-2.3) (1.9-4.0)
Heart 0.117 0.191 163
(0.095-0.146) (0.162-0.210)
Kidney 0.337 0.578 172
(0.288-0.400) (0.496-0.676)
Ovaries 0.010 0.014 *
(0.006-0.020) (0.008-0.024)
* No significant difference.
Histological examination of hematoxylin and eosin-stained sections of
the hearts and kidneys of obese mice and controls revealed no obvious
differences between the groups.
The only other autopsy finding of interest was the observation that the
mean weight of the ovaries of obese mice was 14.7 mg. (range 8-24) while
that of the controls was 10.0 mg. (6-20). This is not regarded as a
statistically significant difference.
DISCUSSION
Aurothioglucose is an analogue of glucose; its structure is shown in
Figure 7. That a single large dose of the compound in the mouse can pro-
duce a marked increase in spontaneous food intake with the subsequent
development of obesity there can be no doubt. There is no evidence to sup-
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port the view that the obesity is due to any cause other than the increased
food intake. Thus, it is currently believed that ATG poisoning can best be
visualized as a biochemical lesion of certain cells which have a critical func-
tion in the normal regulation of intake to energy expenditure. The anatomi-
cal location of these cells and their precise function are quite unknown.
Brecher' and Haymaker18 report that extensive examination of the brains
of obese mice failed to reveal any lesions which might help to explain the
obesity. It is possible that re-investigation of this problem by means of
recently developed sulfhydryl staining techniques will yield new and useful
information.
Brecher' and Owen, et al.24 agree that prior starvation reduces mortality
H
AuS-2
H-C-OH
HO-C-H 0
H-C-Oj
H-C
H-C-OH
FIG. 7. The struc-
ture of aurothioglu-
cose.
from ATG, and the present results are in agreement
with those of Owen, et al. insofar as they indicate an
increased obesity incidence among the survivors in
starvation studies. The mechanism of the increased
resistance to the toxicity of ATG associated with
starvation is not known. Three possibilities may be
considered: (i) it may be related to the decrease in
total metabolism incident to starvation, (ii) it may be
related to the shift from a predominantly carbohydrate
to a predominantly fat metabolic mixture, a shift which
might be accompanied by some alteration in function
of the "satiety chemoreceptors" which would make
them more vulnerable to the gold compound, or (iii) higher concentrations
of the toxic material may gain access to critical cells in the fed state than
in the fasting state.
In order to examine the possibility that a predominantly fat metabolic
mixture might have contributed to the observed result in the starvation
experiment, the fat-feeding experiment reported above was done. The
markedly diminished survival rate in the fat-diet-adapted group clearly
discredits the hypothesis that a fat metabolic mixture in some way renders
the tissue less vulnerable to the action of ATG.
These experiments together, however, suggest that the hunger-satiety
apparatus may be a far more intricate system than any that has been sug-
gested up to this time. For any satisfactory theory of regulation of food
intake to energy expenditure not only must take into account the fact that
animals can perform this regulation on diets of widely varying composition
but also the possibility that the mechanisms for perceiving satiety may
undergo adaptation to different dietary regimens, and that, as suggested
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by the work of Lundbaek and Stevenson,'7 their vulnerability to chemical
attack may vary in different nutritional states.
The fact that the normal mouse or rat increases the volume of his food
intake when his food is diluted with non-caloric bulk materials24"'1 is indica-
tive of the exquisite sensitivity of the hunger-satiety complex. The failure
of the aurothioglucose mouse to increase an already high volume of food as
found by Owen, et al." should not necessarily be interpreted as a failure of
an hypothetical "volume-regulatory" food intake mechanism. It may indi-
cate nothing more than the possibility that the obese mouse has already
expanded his volume intake to his maximum capacity, and that there is a
mechanical limit beyond which he can increase it no further.
The experiments with BAL reported above failed to dissociate the
lethality of ATG from its obesity-producing potency. There is at least
strong presumptive evidence that a heavy metal is involved in the obesity-
producing lesion. This, in turn, suggests the possibility that the hypothetical
satiety chemoreceptors contain some important sulfhydryl-containing pro-
tein which is more or less permanently inactivated by the gold compound.
ATG obesity, then, is a pharmacological oddity: from the experimental
facts it is possible to infer something about its biochemical locus of action
before anything whatever is known about its anatomical locus of action.
The experiment in which hyperglycemia was associated with enhanced
susceptibility to ATG makes it difficult to postulate a competitive relation-
ship between glucose and its sulfur and gold-containing analogue. It is sug-
gested that some physiological event associated with the induced hyper-
glycemia, possibly insulin secretion, may have facilitated the entrance of
ATG into cells. This hypothesis is being tested currently in studies of the
tissue distribution of gold following injection of aurothioglucose under
various circumstances.
The difficulties of distinguishing cause from effect in physiological studies
of obese animals and their controls are well known to most students of
experimental obesity. ATG obesity in mice affords an opportunity to search
for common denominators in different experimental situations in which one
finds markedly increased food intakes. In the light of reported studies on
hypothalamic obesity in rats,'" '- some of the sequelae of obesity in the ATG
syndrome were regarded primarily as adaptive responses to long continued,
excessive food intake.
In these experiments the obese mouse, like the obese rat with an intact
pancreas, did not exhibit markedly impaired glucose tolerance.' However,
all of these studies were made within five months of the time of injection.
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It is entirely possible that studies of older obese mice will reveal substantial
impairment of glucose tolerance.
Like the hypothalamic obese rat,' ATG obese mice show accumulations of
fat in the liver and a statistically significant increase in serum cholesterol
concentration. Since not only cholesterol but also serum lipoproteins have
been shown to be elevated as a result of acute overfeeding in the human,'
these findings may be regarded as an indication of a common biochemical
response to at least three different types of overeating. The mechanism
involved is unknown. We suggest the possibility that enhanced lipogenesis
from carbohydrate is an adaptive response to overnutrition, and that the
total lipotropic capacity of the animal may be overwhelmed by the rate of
carbohydrate-to-fat transformation in markedly obese animals. In this
connection, it is interesting to note that the livers of obese patients often
show fatty infiltration and impairment of function.'
The present experiments on the subject of the "hypermetabolism" of
obesity require little comment. The splanchnomegaly described in the obese
mice was not seen in ATG-injected mice which did not become obese. Since
there was a suggestion that rats with hypothalamic obesity' also demon-
strated some tendency toward splanchnomegaly in spite of the fact that they
were not very obese in comparison with the mice used in the current study,
the splanchnomegaly may be regarded as one of the adaptations to a per-
sistently high food intake. While this may not be exactly what Grafe11 had
in mind when he postulated his theory of "luxuskonsumption," this does, in
fact, represent a form of "luxuskonsumption" and it has the effect of limit-
ing the further development of obesity. It is pertinent, in this connection, to
recall that rats with hypothalamic obesity were found to excrete about
35 per cent more creatinine per day than did their litter mate controls,>
thus indicating that muscle mass may be increased in association with over-
nutrition and obesity. There was no evidence of skeletal growth in these fat
mice, but it must be recalled that they had practically attained their adult
size at the time of injection. Attempts are now being made to produce this
syndrome in very young rapidly growing mice in an effort to ascertain
whether or not skeletal growth can be affected by markedly increased food
intake.
There are two rather striking differences between ATG obesity in mice
and hypothalamic obesity in the rat that are worthy of comment. First,
histological examination of the kidneys of these animals revealed no lesion
comparable to that seen in rats with hypothalamic lesions.5 This is of inter-
est in the light of Stevenson's'7 opinion that the renal lesion in hypothalamic
rats is related to the hypothalamic lesion rather than to an alteration in food
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habit. Second, ATG obese mice do not show ovarian atrophy, while
hypothalamic-operated rats, whether obese or non-obese, frequently did.'
Again, this suggests the possibility that the ovarian atrophy in the rat with
hypothalamic lesions may have been the result of the lesion rather than of
overnutrition and obesity.
SUMMARY
1. A single injection of a large dose of aurothioglucose (ATG) may
result in a very large increase in spontaneous food intake and marked
obesity in the mouse. This is in confirmation of the original observation of
Brecher and Waxler.
2. Fasting prior to injection increased both the survival rate and the
incidence of obesity among survivors under the conditions of these
experiments.
3. Adaptation of mice to a high fat diet prior to injection markedly
enhanced the toxicity of ATG when the material was injected into non-
fasted animals.
4. When mice were treated simultaneously with ATG and progressively
increasing doses of BAL, there was a progressive increase in survival rate
and a concomitant decrease in obesity incidence among the survivors.
5. When fasted mice were injected with ATG at the height of an hyper-
glycemia induced by the intraperitoneal injection of glucose they showed a
greatly diminished survival rate as compared with normoglycemic fasted
mice.
6. The blood glucose and glucose tolerance of ATG obese mice were not
significantly different from those of appropriate controls.
7. ATG obese mice exhibited statistically significant increases in liver
fat concentration and in serum cholesterol concentration.
8. The absolute oxygen consumption of obese mice was found to be
about 79 per cent greater than that of controls of normal weight. The
oxygen consumption of their liver slices per mg. of nitrogen was found to
be precisely the same as the corresponding value for control mice. However,
it was found that the livers, hearts, and kidneys of the obese mice weighed
between 60 and 80 per cent more than did the respective control organs.
The "hypermetabolism" of obesity is therefore interpreted as being due to
an increase in "active metabolic mass," which may have occurred as an
adaptive response to overnutrition and obesity.
9. Certain points of similarity and difference between ATG obesity in
the mouse and hypothalamic obesity in the rat are discussed.
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